PUBLISHER: IMARC | PRODUCT CODE: 1291623
PUBLISHER: IMARC | PRODUCT CODE: 1291623
Nuclear Medicine Radioisotopes Market by Product, Applications, End User, and Region 2023-2028
Market Overview:
The global nuclear medicine radioisotopes market size reached US$ 6.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.44 Billion by 2028, exhibiting a growth rate (CAGR) of 8.60% during 2023-2028. The rising prevalence of cancer, the escalating demand for nuclear medicines, and various technological advancements represent some of the key factors driving the market.
Nuclear medicine radioisotopes are radioactive substances that are used in diagnostic and therapeutic procedures for various medical conditions. These radioisotopes emit radiation, which can be detected and measured to provide information about the structure and function of organs and tissues in the body. They are mainly utilized for diagnostic and therapeutic applications. In diagnostic applications, radioisotopes are employed to create images of the body's internal organs and systems. This allows healthcare professionals to identify abnormalities and diagnose conditions such as cancer, heart disease, and neurological disorders. On the other hand, in therapeutic applications, radioisotopes are used to deliver targeted radiation therapy to cancer cells or other abnormal tissues in the body. Moreover, nuclear medicine radioisotopes have several advantages over traditional diagnostic and therapeutic procedures as they are non-invasive, do not require surgical incisions or other invasive procedures, and have a lower risk of side effects and complications compared to treatments such as chemotherapy or radiation therapy. Owing to these benefits, nuclear medicine radioisotopes are widely utilized in hospitals across the globe.
Nuclear Medicine Radioisotopes Market Trends:
The market is primarily driven by the growing prevalence of cancer among individuals. Nuclear medicine radioisotopes are widely used in cancer diagnosis solutions such as PET scans and treatment therapies. In addition, the rising geriatric population that is more susceptible to chronic diseases such as cancer, heart disease, and neurological disorders, which require the use of nuclear medicine radioisotopes, represents another major growth-inducing factor. Besides this, various technological advancements have led to the development of new and improved diagnostic and therapeutic applications of nuclear medicine radioisotopes. This, coupled with the increasing investment and demand for nuclear medicines, is positively influencing market growth. Governments and private organizations are investing heavily in the research and development of nuclear medicine technologies, leading to the creation of new products and applications, which in turn is driving the market growth. Moreover, the market is also propelled by the growing patient awareness about radiation and radiation therapy. Furthermore, the rising healthcare expenditure, the launch of advanced product variants, and increasing research and development activities conducted by key players are other factors creating a favorable market outlook.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global nuclear medicine radioisotopes market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product, application and end user.
Product Insights:
- Diagnostics
- Technetium-99m (Tc-99m)
- Gallium-67
- Thallium-201
- Fluorine-18
- Others
- Therapeutics
- Rhenium-186
- Iodine-131
- Samarium-153
- Yttrium-90
- Others
The report has provided a detailed breakup and analysis of the nuclear medicine radioisotopes market based on the product. This includes diagnostics [technetium-99m (Tc-99m), gallium-67, thallium-201, fluorine-18, and others] and therapeutics (rhenium-186, iodine-131, samarium-153, yttrium-90, and others). According to the report, diagnostics (technetium-99m (Tc-99m) represented the largest segment.
Application Insights:
- Cardiology
- Oncology
- Thyroid
- Neurology
- Others
A detailed breakup and analysis of the nuclear medicine radioisotopes market based on the application has also been provided in the report. This includes cardiology, oncology, thyroid, neurology, and others. According to the report, cardiology accounted for the largest market share.
End User Insights:
- Hospitals
- Diagnostic Centers
- Specialty Clinics
- Education and Research Institutes
- Others
The report has provided a detailed breakup and analysis of the nuclear medicine radioisotopes market based on the end user. This includes hospitals, diagnostic centers, specialty clinics, education and research institutes, and others.
Regional Insights:
- North America
- United States
- Canada
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for nuclear medicine radioisotopes. Some of the factors driving the North America nuclear medicine radioisotopes market included aging population, technological advancements, rising prevalence of cancer.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global nuclear medicine radioisotopes market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Bracco S.p.A., Bruce Power Inc., Cardinal Health Inc., China Isotope & Radiation Corporation (China National Nuclear Corporation), Curium Pharma, Eckert & Ziegler, Nordion (Canada) Inc (Sotera Health Company), NorthStar Medical Radioisotopes, LLC, NTP Radioisotopes SOC Ltd.,Shine Technologies LLC, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
- How has the global nuclear medicine radioisotopes market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global nuclear medicine radioisotopes market?
- What is the impact of each driver, restraint, and opportunity on the global nuclear medicine radioisotopes market?
- What are the key regional markets?
- Which countries represent the most attractive nuclear medicine radioisotopes market?
- What is the breakup of the market based on the product?
- Which is the most attractive product in the nuclear medicine radioisotopes market?
- What is the breakup of the market based on the application?
- Which is the most attractive application in the nuclear medicine radioisotopes market?
- What is the breakup of the market based on end user?
- Which is the most attractive end user in the nuclear medicine radioisotopes market?
- What is the competitive structure of the global nuclear medicine radioisotopes market?
- Who are the key players/companies in the global nuclear medicine radioisotopes market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Nuclear Medicine Radioisotopes Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Diagnostics
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Technetium-99m (Tc-99m)
- 6.1.2.2 Gallium-67
- 6.1.2.3 Thallium-201
- 6.1.2.4 Fluorine-18
- 6.1.2.5 Others
- 6.1.3 Market Forecast
- 6.2 Therapeutic
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Rhenium-186
- 6.2.2.2 Iodine-131
- 6.2.2.3 Samarium-153
- 6.2.2.4 Yttrium-90
- 6.2.2.5 Others
- 6.2.3 Market Forecast
7 Market Breakup by Application
- 7.1 Cardiology
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Oncology
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Thyroid
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Neurology
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Diagnostic Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Specialty Clinics
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Education and Research Institutes
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
- 10.1 Overview
- 10.2 Drivers
- 10.3 Restraints
- 10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Bracco S.p.A.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 SWOT Analysis
- 14.3.2 Bruce Power Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 SWOT Analysis
- 14.3.3 Cardinal Health Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 China Isotope & Radiation Corporation (China National Nuclear Corporation)
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.5 Curium Pharma
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 Eckert & Ziegler
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.7 Nordion (Canada) Inc (Sotera Health Company)
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 SWOT Analysis
- 14.3.8 NorthStar Medical Radioisotopes, LLC
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.9 NTP Radioisotopes SOC Ltd
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 Shine Technologies LLC
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.1 Bracco S.p.A.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
List of Figures
- Figure 1: Global: Nuclear Medicine Radioisotopes Market: Major Drivers and Challenges
- Figure 2: Global: Nuclear Medicine Radioisotopes Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 4: Global: Nuclear Medicine Radioisotopes Market: Breakup by Product (in %), 2022
- Figure 5: Global: Nuclear Medicine Radioisotopes Market: Breakup by Application (in %), 2022
- Figure 6: Global: Nuclear Medicine Radioisotopes Market: Breakup by End User (in %), 2022
- Figure 7: Global: Nuclear Medicine Radioisotopes Market: Breakup by Region (in %), 2022
- Figure 8: Global: Nuclear Medicine Radioisotopes (Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 9: Global: Nuclear Medicine Radioisotopes (Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 10: Global: Nuclear Medicine Radioisotopes (Therapeutic) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 11: Global: Nuclear Medicine Radioisotopes (Therapeutic) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 12: Global: Nuclear Medicine Radioisotopes (Cardiology) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 13: Global: Nuclear Medicine Radioisotopes (Cardiology) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 14: Global: Nuclear Medicine Radioisotopes (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 15: Global: Nuclear Medicine Radioisotopes (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 16: Global: Nuclear Medicine Radioisotopes (Thyroid) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 17: Global: Nuclear Medicine Radioisotopes (Thyroid) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 18: Global: Nuclear Medicine Radioisotopes (Neurology) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 19: Global: Nuclear Medicine Radioisotopes (Neurology) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 20: Global: Nuclear Medicine Radioisotopes (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 21: Global: Nuclear Medicine Radioisotopes (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 22: Global: Nuclear Medicine Radioisotopes (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 23: Global: Nuclear Medicine Radioisotopes (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 24: Global: Nuclear Medicine Radioisotopes (Diagnostic Centers) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 25: Global: Nuclear Medicine Radioisotopes (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 26: Global: Nuclear Medicine Radioisotopes (Specialty Clinics) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 27: Global: Nuclear Medicine Radioisotopes (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 28: Global: Nuclear Medicine Radioisotopes (Education and Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 29: Global: Nuclear Medicine Radioisotopes (Education and Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 30: Global: Nuclear Medicine Radioisotopes (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 31: Global: Nuclear Medicine Radioisotopes (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 32: North America: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2017 & 2022
- Figure 33: North America: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 34: United States: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2017 & 2022
- Figure 35: United States: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 36: Canada: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2017 & 2022
- Figure 37: Canada: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 38: Asia-Pacific: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2017 & 2022
- Figure 39: Asia-Pacific: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 40: China: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2017 & 2022
- Figure 41: China: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 42: Japan: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2017 & 2022
- Figure 43: Japan: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 44: India: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2017 & 2022
- Figure 45: India: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 46: South Korea: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2017 & 2022
- Figure 47: South Korea: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 48: Australia: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2017 & 2022
- Figure 49: Australia: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 50: Indonesia: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2017 & 2022
- Figure 51: Indonesia: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 52: Others: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2017 & 2022
- Figure 53: Others: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 54: Europe: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2017 & 2022
- Figure 55: Europe: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 56: Germany: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2017 & 2022
- Figure 57: Germany: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 58: France: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2017 & 2022
- Figure 59: France: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 60: United Kingdom: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2017 & 2022
- Figure 61: United Kingdom: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 62: Italy: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2017 & 2022
- Figure 63: Italy: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 64: Spain: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2017 & 2022
- Figure 65: Spain: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 66: Russia: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2017 & 2022
- Figure 67: Russia: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 68: Others: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2017 & 2022
- Figure 69: Others: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 70: Latin America: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2017 & 2022
- Figure 71: Latin America: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 72: Brazil: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2017 & 2022
- Figure 73: Brazil: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 74: Mexico: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2017 & 2022
- Figure 75: Mexico: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 76: Others: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2017 & 2022
- Figure 77: Others: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 78: Middle East and Africa: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2017 & 2022
- Figure 79: Middle East and Africa: Nuclear Medicine Radioisotopes Market: Breakup by Country (in %), 2022
- Figure 80: Middle East and Africa: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 81: Global: Nuclear Medicine Radioisotopes Industry: Drivers, Restraints, and Opportunities
- Figure 82: Global: Nuclear Medicine Radioisotopes Industry: Value Chain Analysis
- Figure 83: Global: Nuclear Medicine Radioisotopes Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Nuclear Medicine Radioisotopes Market: Key Industry Highlights, 2022 & 2028
- Table 2: Global: Nuclear Medicine Radioisotopes Market Forecast: Breakup by Product (in Million US$), 2023-2028
- Table 3: Global: Nuclear Medicine Radioisotopes Market Forecast: Breakup by Application (in Million US$), 2023-2028
- Table 4: Global: Nuclear Medicine Radioisotopes Market Forecast: Breakup by End User (in Million US$), 2023-2028
- Table 5: Global: Nuclear Medicine Radioisotopes Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 6: Global: Nuclear Medicine Radioisotopes Market: Competitive Structure
- Table 7: Global: Nuclear Medicine Radioisotopes Market: Key Players
